With EUR 56m investment, Krka doubles R&D capacities
Novo Mesto, 1 October - Krka, the Novo Mesto-seated pharmaceuticals group, has launched a new research and development centre to nearly double its R&D, and control and analysis capacities.
The rest of this news item is available to subscribers.
The news item consists of 1.538 characters (without spaces) or 304 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.